French-born Weber oversaw a reorientation that included the $62 billion acquisition of British rival Shire in 2019.

Man Utd's interest in Mathys Tel appears to have been short-lived as Bayern Munich have agreed a €60 million deal with ...

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Management View Christophe Weber, CEO, announced his retirement ...

Thursday delivered some massive transfer news as Victor Osimhen's next transfer was confirmed.Plus, Xavi Simons completed a ...

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's ...

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S.

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top drugmaker.

Chelsea are readying a new approach for Manchester United winger Alejandro Garnacho, according to a report. The last few days ...

TOKYO -- Japan's Takeda Pharmaceutical announced on Thursday that CEO Christophe Weber will step down in June 2026 and be succeeded by current U.S. business head Julie Kim, who would become the ...

Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years. | Takeda has named Julie Kim ...

Christophe Weber will step down as CEO of Takeda next year, the company announced, following a dropoff in its share price ...